To conclude, except for CCR6 and CCR10, CD39+ and CD39− Treg in tumors have a largely similar chemokine receptor expression, and chemokine receptor usage alone can probably not explain the preferred accumulation of CD39+ Treg in the tumor. This evidence concerns the gene CCR6 and neoplasm.